title: The glia-derived extracellular matrix glycoprotein tenascin-C promotes embryonic and postnatal retina axon outgrowth via the alternatively spliced fibronectin type III domain TNfnD.
abstract: Tenascin-C (Tnc) is an astrocytic multifunctional extracellular matrix (ECM) glycoprotein that potentially promotes or inhibits neurite outgrowth. To investigate its possible functions for retinal development, explants from embryonic day 18 (E18) rat retinas were cultivated on culture substrates composed of poly-d-lysine (PDL), or PDL additionally coated with Tnc or laminin (LN)-1, which significantly increased fiber length. When combined with LN, Tnc induced axon fasciculation that reduced the apparent number of outgrowing fibers. In order to circumscribe the stimulatory region, Tnc-derived fibronectin type III (TNfn) domains fused to the human Ig-Fc-fragment TNfnD6-Fc, TNfnBD-Fc, TNFnA1A2-Fc and TNfnA1D-Fc were studied. The fusion proteins TNfnBD-Fc and to a lesser degree TNfnA1D-Fc were stimulatory when compared with the Ig-Fc-fragment protein without insert. In contrast, the combination TNfnA1A2-Fc reduced fiber outgrowth beneath the values obtained for the Ig-Fc domain, indicating potential inhibitory properties. The monoclonal J1/tn2 antibody (clone 578) that is specific for domain TNfnD blocked the stimulatory properties of the TNfn-Fc fusions. When postnatal day 7 retinal ganglion cells were used rather that explants, Tnc and Tnc-derived proteins proved permissive for neurite outgrowth. The present study highlights a strong retinal axon growth-promoting activity of the Tnc domain TNfnD, which is modulated by neighboring domains.
authors.affiliation: Department of Cell Morphology and Molecular Neurobiology, Ruhr-University, Bochum, Germany.
authors.forename: Sonia
authors.initials: S
authors.lastname: Siddiqui
authors.forename: Andrea
authors.initials: A
authors.lastname: Horvat-Bröcker
authors.forename: Andreas
authors.initials: A
authors.lastname: Faissner
mesh_terms: D000367:Age Factors; D017398:Alternative Splicing / Q000502:physiology*; D000818:Animals; D000831:Animals, Newborn; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001369:Axons / Q000187:drug effects*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian; D005260:Female; D005353:Fibronectins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000235:genetics / Q000378:metabolism; D066298:In Vitro Techniques; D007797:Laminin / Q000378:metabolism; D009433:Neural Inhibition / Q000187:drug effects / Q000235:genetics; D011247:Pregnancy; D017434:Protein Structure, Tertiary / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D012160:Retina / Q000166:cytology / Q000196:embryology / Q000254:growth & development; D012165:Retinal Ganglion Cells / Q000166:cytology*; D019063:Tenascin / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*
chemical_list: D000911:Antibodies, Monoclonal; D005353:Fibronectins; D007141:Immunoglobulin Fc Fragments; D007797:Laminin; D011993:Recombinant Fusion Proteins; D019063:Tenascin; C121346:laminin 1